Aldosterone reduces baroreceptor discharge in the dog

Wei Wang, Joseph M. McClain, Irving H Zucker

Research output: Contribution to journalArticle

113 Citations (Scopus)

Abstract

We have previously demonstrated that baroreceptor discharge sensitivity is depressed in dogs with experimental heart failure and that this depressed sensitivity can be reversed by the Na+,K+-ATPase inhibitor ouabain. This suggests that enhanced Na+,K+-ATPase activity in baroreceptors is responsible for the blunted baroreceptor discharge sensitivity seen in heart failure state. Because aldosterone, a known stimulator of Na+,K+-ATPase, is elevated in heart failure the present study was undertaken to determine the effects on baroreceptor discharge of perfusion of the carotid sinus with aldosterone in normotensive dogs. Single unit baroreceptor activity was recorded as well as carotid sinus pressure and the diameter of the carotid sinus. Perfusion of the carotid sinus with aldosterone (in Krebs-Henseleit solution) significantly elevated threshold pressure (108.5±3.1 mm Hg versus 92.7±4.6 mm Hg, p < 0.05) and reduced peak discharge rate (40.3±3.9 spikes/sec versus 47.9±3.6 spikes/sec, p < 0.05). These effects appeared 15 minutes after aldosterone perfusion and remained constant for the next 60 minutes. There was no change in the carotid sinus pressure-diameter curve during perfusion with aldosterone. Perfusion of the carotid sinus with ouabain (0.1 μg/ml) during aldosterone perfusion did not reverse the blunted baroreceptor discharge. The blunted baroreceptor activity induced by perfusion of the carotid sinus with aldosterone was prevented by removal of the endothelial cells in the carotid sinus area with a balloon-tipped catheter or by perfusion with saponin. Finally, perfusion of the carotid sinus with spironolactone (10 ng/ml), a mineralocorticoid receptor antagonist, prevented the inhibitory effect of aldosterone. These data suggest that aldosterone reduces maximum baroreceptor discharge. The mechanism for this effect does not appear to involve Na+,K+-ATPase. It is, however, related to some aspect of carotid sinus endothelial cell function.

Original languageEnglish (US)
Pages (from-to)270-277
Number of pages8
JournalHypertension
Volume19
Issue number3
DOIs
StatePublished - Jan 1 1992

Fingerprint

Carotid Sinus
Pressoreceptors
Aldosterone
Dogs
Perfusion
Heart Failure
Ouabain
Pressure
Endothelial Cells
Mineralocorticoid Receptor Antagonists
Spironolactone
Saponins
Catheters

Keywords

  • aldosterone
  • baroreceptors
  • carotid sinus
  • dog studies
  • endothelium
  • ouabain
  • saponins
  • sodium-potassium ATPase
  • spironolactone

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Aldosterone reduces baroreceptor discharge in the dog. / Wang, Wei; McClain, Joseph M.; Zucker, Irving H.

In: Hypertension, Vol. 19, No. 3, 01.01.1992, p. 270-277.

Research output: Contribution to journalArticle

Wang, Wei ; McClain, Joseph M. ; Zucker, Irving H. / Aldosterone reduces baroreceptor discharge in the dog. In: Hypertension. 1992 ; Vol. 19, No. 3. pp. 270-277.
@article{1b7493285afc45d382c2c46d88be14a3,
title = "Aldosterone reduces baroreceptor discharge in the dog",
abstract = "We have previously demonstrated that baroreceptor discharge sensitivity is depressed in dogs with experimental heart failure and that this depressed sensitivity can be reversed by the Na+,K+-ATPase inhibitor ouabain. This suggests that enhanced Na+,K+-ATPase activity in baroreceptors is responsible for the blunted baroreceptor discharge sensitivity seen in heart failure state. Because aldosterone, a known stimulator of Na+,K+-ATPase, is elevated in heart failure the present study was undertaken to determine the effects on baroreceptor discharge of perfusion of the carotid sinus with aldosterone in normotensive dogs. Single unit baroreceptor activity was recorded as well as carotid sinus pressure and the diameter of the carotid sinus. Perfusion of the carotid sinus with aldosterone (in Krebs-Henseleit solution) significantly elevated threshold pressure (108.5±3.1 mm Hg versus 92.7±4.6 mm Hg, p < 0.05) and reduced peak discharge rate (40.3±3.9 spikes/sec versus 47.9±3.6 spikes/sec, p < 0.05). These effects appeared 15 minutes after aldosterone perfusion and remained constant for the next 60 minutes. There was no change in the carotid sinus pressure-diameter curve during perfusion with aldosterone. Perfusion of the carotid sinus with ouabain (0.1 μg/ml) during aldosterone perfusion did not reverse the blunted baroreceptor discharge. The blunted baroreceptor activity induced by perfusion of the carotid sinus with aldosterone was prevented by removal of the endothelial cells in the carotid sinus area with a balloon-tipped catheter or by perfusion with saponin. Finally, perfusion of the carotid sinus with spironolactone (10 ng/ml), a mineralocorticoid receptor antagonist, prevented the inhibitory effect of aldosterone. These data suggest that aldosterone reduces maximum baroreceptor discharge. The mechanism for this effect does not appear to involve Na+,K+-ATPase. It is, however, related to some aspect of carotid sinus endothelial cell function.",
keywords = "aldosterone, baroreceptors, carotid sinus, dog studies, endothelium, ouabain, saponins, sodium-potassium ATPase, spironolactone",
author = "Wei Wang and McClain, {Joseph M.} and Zucker, {Irving H}",
year = "1992",
month = "1",
day = "1",
doi = "10.1161/01.HYP.19.3.270",
language = "English (US)",
volume = "19",
pages = "270--277",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Aldosterone reduces baroreceptor discharge in the dog

AU - Wang, Wei

AU - McClain, Joseph M.

AU - Zucker, Irving H

PY - 1992/1/1

Y1 - 1992/1/1

N2 - We have previously demonstrated that baroreceptor discharge sensitivity is depressed in dogs with experimental heart failure and that this depressed sensitivity can be reversed by the Na+,K+-ATPase inhibitor ouabain. This suggests that enhanced Na+,K+-ATPase activity in baroreceptors is responsible for the blunted baroreceptor discharge sensitivity seen in heart failure state. Because aldosterone, a known stimulator of Na+,K+-ATPase, is elevated in heart failure the present study was undertaken to determine the effects on baroreceptor discharge of perfusion of the carotid sinus with aldosterone in normotensive dogs. Single unit baroreceptor activity was recorded as well as carotid sinus pressure and the diameter of the carotid sinus. Perfusion of the carotid sinus with aldosterone (in Krebs-Henseleit solution) significantly elevated threshold pressure (108.5±3.1 mm Hg versus 92.7±4.6 mm Hg, p < 0.05) and reduced peak discharge rate (40.3±3.9 spikes/sec versus 47.9±3.6 spikes/sec, p < 0.05). These effects appeared 15 minutes after aldosterone perfusion and remained constant for the next 60 minutes. There was no change in the carotid sinus pressure-diameter curve during perfusion with aldosterone. Perfusion of the carotid sinus with ouabain (0.1 μg/ml) during aldosterone perfusion did not reverse the blunted baroreceptor discharge. The blunted baroreceptor activity induced by perfusion of the carotid sinus with aldosterone was prevented by removal of the endothelial cells in the carotid sinus area with a balloon-tipped catheter or by perfusion with saponin. Finally, perfusion of the carotid sinus with spironolactone (10 ng/ml), a mineralocorticoid receptor antagonist, prevented the inhibitory effect of aldosterone. These data suggest that aldosterone reduces maximum baroreceptor discharge. The mechanism for this effect does not appear to involve Na+,K+-ATPase. It is, however, related to some aspect of carotid sinus endothelial cell function.

AB - We have previously demonstrated that baroreceptor discharge sensitivity is depressed in dogs with experimental heart failure and that this depressed sensitivity can be reversed by the Na+,K+-ATPase inhibitor ouabain. This suggests that enhanced Na+,K+-ATPase activity in baroreceptors is responsible for the blunted baroreceptor discharge sensitivity seen in heart failure state. Because aldosterone, a known stimulator of Na+,K+-ATPase, is elevated in heart failure the present study was undertaken to determine the effects on baroreceptor discharge of perfusion of the carotid sinus with aldosterone in normotensive dogs. Single unit baroreceptor activity was recorded as well as carotid sinus pressure and the diameter of the carotid sinus. Perfusion of the carotid sinus with aldosterone (in Krebs-Henseleit solution) significantly elevated threshold pressure (108.5±3.1 mm Hg versus 92.7±4.6 mm Hg, p < 0.05) and reduced peak discharge rate (40.3±3.9 spikes/sec versus 47.9±3.6 spikes/sec, p < 0.05). These effects appeared 15 minutes after aldosterone perfusion and remained constant for the next 60 minutes. There was no change in the carotid sinus pressure-diameter curve during perfusion with aldosterone. Perfusion of the carotid sinus with ouabain (0.1 μg/ml) during aldosterone perfusion did not reverse the blunted baroreceptor discharge. The blunted baroreceptor activity induced by perfusion of the carotid sinus with aldosterone was prevented by removal of the endothelial cells in the carotid sinus area with a balloon-tipped catheter or by perfusion with saponin. Finally, perfusion of the carotid sinus with spironolactone (10 ng/ml), a mineralocorticoid receptor antagonist, prevented the inhibitory effect of aldosterone. These data suggest that aldosterone reduces maximum baroreceptor discharge. The mechanism for this effect does not appear to involve Na+,K+-ATPase. It is, however, related to some aspect of carotid sinus endothelial cell function.

KW - aldosterone

KW - baroreceptors

KW - carotid sinus

KW - dog studies

KW - endothelium

KW - ouabain

KW - saponins

KW - sodium-potassium ATPase

KW - spironolactone

UR - http://www.scopus.com/inward/record.url?scp=0026718015&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026718015&partnerID=8YFLogxK

U2 - 10.1161/01.HYP.19.3.270

DO - 10.1161/01.HYP.19.3.270

M3 - Article

VL - 19

SP - 270

EP - 277

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 3

ER -